SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Groupe Bruxelles Lambert (Last) (First) (Middle) C/O GROUPE BRUXELLES LAMBERT 24 AVENUE MARNIX (Street) BRUSSELLS C9 1000 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 09/25/2023	3. Issuer Name and Ticker or Trading Symbol Concentrix Corp [ CNXC ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director X 10% Owner Officer (give title below) Other (specify below)	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting Person X Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	8,773,667(1)	I	See Footnotes(2)(3)(4)(5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Contingent Right to Common Stock	(6)	(6)	Common Stock	442,759	(6)	I	See Footnote(6)

1. Name and Address of Reporting Person* Groupe Bruxelles Lambert (Last) (First) (Middle) C/O GROUPE BRUXELLES LAMBERT 24 AVENUE MARNIX (Street) BRUSSELLS C9 1000 (City) (State) (Zip)

1. Name and Address of Reporting Person* FINPAR VI SA (Last) (First) (Middle) C/O GROUPE BRUXELLES LAMBERT 24 AVENUE MARNIX (Street) BRUSSELLS C9 1000 (City) (State) (Zip)

1. Name and Address of Reporting Person* FINPAR V SA (Last) (First) (Middle) C/O GROUPE BRUXELLES LAMBERT 24 AVENUE MARNIX (Street) BRUSSELLS C9 1000 (City) (State) (Zip)

1. Name and Address of Reporting Person* Sapiens S.a r.l. (Last) (First) (Middle) C/O GROUPE BRUXELLES LAMBERT 24 AVENUE MARNIX (Street) BRUSSELLS C9 1000 (City) (State) (Zip)

1. Name and Address of Reporting Person* GBL Verwaltung S.A. (Last) (First) (Middle) C/O GROUPE BRUXELLES LAMBERT 24 AVENUE MARNIX (Street) BRUSSELLS C9 1000 (City) (State) (Zip)

Explanation of Responses:

1. Reflects shares of Common Stock, par value $0.0001 per share ("Common Stock"), of Concentrix Corporation (the "Issuer") that were issued in connection with the consummation of transactions contemplated by the Share Purchase and Contribution Agreement (the "SPA"), dated as of June 12, 2023, by and among the Issuer and OSYRIS S.A R.L., MARNIX LUX SA, the Sellers named therein and the Seller Representatives.

2. 38,623 shares are held directly by FINPAR VI SA, 35,964 shares are held directly by FINPAR V SA and 8,699,080 shares are held directly by Sapiens S.ar.l. (the "Direct Holders").

3. GBL Verwaltung S.A. is the parent company of Sapiens S.a r.l. Groupe Bruxelles Lambert is the parent company of GBL Verwaltung S.A., Sapiens S.a r.l, FINPAR VI SA and of FINPAR V SA.

4. Information with respect to each of the Reporting Persons is given solely by such Reporting Person, and no Reporting Person has responsibility for the accuracy or completeness of information supplied by another Reporting Person.

5. Each of the Reporting Persons (other than to the extent it directly holds securities reported herein) disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such Reporting Person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, each of the Reporting Persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose.

6. Pursuant to, and subject to the terms and conditions in, the SPA, the Direct Holders have the contingent right to receive up to 442,759 shares of Common Stock if the share price of the Common Stock reaches $170.00 per share within seven years from September 25, 2023 (based on daily volume weighted average prices measured over a specific period), or if within three years from September 25, 2023 the Issuer has a change of control with per share consideration of at least $150.00. FINPAR VI SA has the contingent right to receive up to 1,949 shares of Common Stock. FINPAR V SA has the contingent right to receive up to 1,814 shares of Common Stock. Sapiens S.ar.l. has the contingent right to receive up to 438,996 shares of Common Stock.

	FINPAR VI SA, By: /s/ Priscilla Maters, Name: Priscilla Maters, Title: Director	10/05/2023
	FINPAR VI SA, By: /s/ Xavier Likin, Name: Xavier Likin, Title: Director	10/05/2023
	FINPAR V SA, By: /s/ Priscilla Maters, Name: Priscilla Maters, Title: Director	10/05/2023
	FINPAR V SA, By: /s/ Xavier Likin, Name: Xavier Likin, Title: Director	10/05/2023
	Sapiens S.ar.l., By: /s/ Priscilla Maters, Name: Priscilla Maters, Title: Director	10/05/2023
	Sapiens S.ar.l., By: /s/ Serge Saussoy, Name: Serge Saussoy, Title: Director	10/05/2023
	GBL Verwaltung S.A., By: /s/ Priscilla Maters, Name: Priscilla Maters, Title: Director	10/05/2023
	GBL Verwaltung S.A., By: /s/ Serge Saussoy, Name: Serge Saussoy, Title: Director	10/05/2023
	Groupe Bruxelles Lambert., By: /s/ Priscilla Maters, Name: Priscilla Maters, Title: General Counsel	10/05/2023
	Groupe Bruxelles Lambert., By: /s/ Xavier Likin, Name: Xavier Likin, Title: Chief Financial Officer	10/05/2023
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.